Literature DB >> 5559436

Epidemiology of systemic sclerosis (scleroderma).

T A Medsger, A T Masi.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5559436     DOI： 10.7326/0003-4819-74-5-714

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  46 in total

1.  European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.

Authors:  A Della Rossa; G Valentini; S Bombardieri; W Bencivelli; A J Silman; S D'Angelo; M M Cerinic; J F Belch; C M Black; R Becvar; P Bruhlman; F Cozzi; L Czirják; A A Drosos; B Dziankowska; C Ferri; A Gabrielli; R Giacomelli; G Hayem; M Inanc; N J McHugh; H Nielsen; R Scorza; E Tirri; F H van den Hoogen; P G Vlachoyiannopoulos
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

Authors:  A J Silman; S Jones
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 3.  A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.

Authors:  E Hachulla; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

4.  Renal disease in systemic sclerosis with normal serum creatinine.

Authors:  Reem H A Mohamed; Hania S Zayed; Amr Amin
Journal:  Clin Rheumatol       Date:  2010-02-23       Impact factor: 2.980

5.  Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study.

Authors:  Chris T Derk; Carol M Artlett; Sergio A Jimenez
Journal:  Clin Rheumatol       Date:  2006-01-25       Impact factor: 2.980

Review 6.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

7.  Late-age onset systemic sclerosis.

Authors:  Rebecca L Manno; Fredrick M Wigley; Allan C Gelber; Laura K Hummers
Journal:  J Rheumatol       Date:  2011-06-17       Impact factor: 4.666

8.  Prostaglandin-mediated inhibition of lymphokine secretion in normal individuals and patients with progressive systemic sclerosis (scleroderma, PSS).

Authors:  R H Kelly; D H Miller; G P Rodnan; J Hagmann
Journal:  Agents Actions       Date:  1982-10

Review 9.  [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].

Authors:  H J Girschick
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

10.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

Authors:  T Mimori; M Akizuki; H Yamagata; S Inada; S Yoshida; M Homma
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.